# FDA Inspection 1181399 - Biomat USA Inc - September 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bf6686d0-2159-49e1-9fae-4405551b656a
Source feed: FDA_Inspections

> FDA Inspection 1181399 for Biomat USA Inc on September 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181399
- Company Name: Biomat USA Inc
- Inspection Date: 2022-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181399 - 2022-09-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5c5648bd-51a6-451b-a2c5-888b0eeafb44)
- [FDA Inspection 1008201 - 2017-03-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6dc97674-19e9-40e1-a915-7f906c301f32)
- [FDA Inspection 868558 - 2014-02-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9e0948bb-9c72-4f45-aa65-47c4d5168e54)

Company: https://www.keypedia.com/companies/biomat-usa-inc/af883884-f0bf-43ae-81bf-865ae1f44061

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d